HopeStage
Back to all studies
CompletedNCT07524777

Ganoderma Spores Modulate the Gut-Brain Axis

Placebo comparisonAges 18–80ChinaDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 80 years.

Listed locations
HangzhouSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: April 11, 2026
Recruitment status
Completed
Enrollment listed in the registry
300
Sponsor
Ling Zhiqiang
Sponsor type
Unknown or unclear
Study type
Other
Intervention type
Dietary supplement, Other
Locations
China
Age range
From 18 Years to 80 Years
Official registry ID
NCT07524777
Official title
Show the full official title

Targeting the Gut-Brain Axis With Ganoderma Lucidum Spores Ameliorates Depression in Thyroid Cancer Patients: a Randomized, Double-blind, Placebo-controlled Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Hangzhou

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Ling Zhiqiang.

Who was this study for?

Listed age limits: 18 years to 80 years.

Want to explore more studies?

Explore studies